Search alternatives:
significantly point » significantly onto (Expand Search), significantly poorer (Expand Search), significantly lower (Expand Search)
point decrease » point increase (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
significantly point » significantly onto (Expand Search), significantly poorer (Expand Search), significantly lower (Expand Search)
point decrease » point increase (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
1
-
2
-
3
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
Published 2025“…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”
-
4
-
5
-
6
-
7
Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae
Published 2025“…Developing efficient and accurate detection of resistant strains is urgently needed for their management and treatment. We have developed the Multiplex Integrated RPA-CRISPR/Cas12a detection Assay (MIRCA) for simultaneous detection of Neisseria gonorrheae (<i>Ng</i>) and mutations with decreased susceptibility to cephalosporins. …”
-
8
-
9
-
10
-
11
-
12
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
13
-
14
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
15
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
16
-
17
-
18
-
19
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
20
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: